Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis

PURPOSE: The aim of this study was to explore the value of adjuvant chemotherapy in patients with early-stage ER/PR-positive mucinous carcinoma. METHODS: We identified early-stage ER/PR-positive mucinous carcinoma patients in the Surveillance, Epidemiology, and End Results (SEER) database. We used p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hong-Fei, Li, Wei-Ping, Zhu, Teng, Yang, Ci-Qiu, Yang, Mei, Zhang, Liu-Lu, Ji, Fei, Cheng, Min-Yi, Li, Jie-Qing, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502365/
https://www.ncbi.nlm.nih.gov/pubmed/32947149
http://dx.doi.org/10.1016/j.breast.2020.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502365/
https://www.ncbi.nlm.nih.gov/pubmed/32947149
http://dx.doi.org/10.1016/j.breast.2020.09.003

Ejemplares similares